Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. filed an 8-K with the SEC on April 7, 2026, under the legacy ticker SRNG — the original exchange symbol for Soaring Eagle Acquisition Corp., the blank-check vehicle sponsored by Eagle Equity Partners that took Ginkgo public through a de-SPAC merger completed in 2021. Ginkgo operates in the synthetic biology sector, offering a cell-programming platform with applications spanning pharmaceuticals, agriculture, and industrial biotechnology. The current report represents routine post-merger disclosure activity filed under the company's EDGAR entity inherited from the SPAC transaction. Sign up on SpacDesk for full filing history, sponsor profiles, and real-time analytics across the SPAC universe.